HK1172021A1 - 5-(3,4-dichloro-phenyl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro- ethoxy)-nicotinamide and salts thereof as hdl cholesterol raising agents hdl 5-(34--)-n-(2--)-6-(222-- )- - Google Patents

5-(3,4-dichloro-phenyl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro- ethoxy)-nicotinamide and salts thereof as hdl cholesterol raising agents hdl 5-(34--)-n-(2--)-6-(222-- )-

Info

Publication number
HK1172021A1
HK1172021A1 HK12112824.3A HK12112824A HK1172021A1 HK 1172021 A1 HK1172021 A1 HK 1172021A1 HK 12112824 A HK12112824 A HK 12112824A HK 1172021 A1 HK1172021 A1 HK 1172021A1
Authority
HK
Hong Kong
Prior art keywords
hdl
nicotinamide
trifluoro
dichloro
ethoxy
Prior art date
Application number
HK12112824.3A
Other languages
English (en)
Chinese (zh)
Inventor
斯蒂芬．勒韋爾
馬修．賴特
Original Assignee
霍夫曼-拉羅奇有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 霍夫曼-拉羅奇有限公司 filed Critical 霍夫曼-拉羅奇有限公司
Publication of HK1172021A1 publication Critical patent/HK1172021A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK12112824.3A 2009-09-11 2012-12-12 5-(3,4-dichloro-phenyl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro- ethoxy)-nicotinamide and salts thereof as hdl cholesterol raising agents hdl 5-(34--)-n-(2--)-6-(222-- )- HK1172021A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09170097 2009-09-11
PCT/EP2010/063136 WO2011029827A1 (en) 2009-09-11 2010-09-08 5- (3, 4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as hdl cholesterol raising agents

Publications (1)

Publication Number Publication Date
HK1172021A1 true HK1172021A1 (en) 2013-04-12

Family

ID=42830122

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12112824.3A HK1172021A1 (en) 2009-09-11 2012-12-12 5-(3,4-dichloro-phenyl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro- ethoxy)-nicotinamide and salts thereof as hdl cholesterol raising agents hdl 5-(34--)-n-(2--)-6-(222-- )-

Country Status (35)

Country Link
US (1) US8227491B2 (he)
EP (1) EP2475645B1 (he)
JP (1) JP5604520B2 (he)
KR (1) KR101382871B1 (he)
CN (1) CN102639506B (he)
AR (2) AR078352A1 (he)
AU (1) AU2010294277B2 (he)
BR (1) BR112012005511B8 (he)
CA (1) CA2771493C (he)
CL (1) CL2012000611A1 (he)
CO (1) CO6491033A2 (he)
CR (1) CR20120089A (he)
CY (1) CY1114377T1 (he)
DK (1) DK2475645T3 (he)
EC (1) ECSP12011723A (he)
ES (1) ES2423821T3 (he)
HK (1) HK1172021A1 (he)
HR (1) HRP20130869T1 (he)
IL (1) IL217920A (he)
IN (1) IN2012DN00763A (he)
MA (1) MA33563B1 (he)
MX (1) MX2012002254A (he)
MY (1) MY161103A (he)
NZ (1) NZ597514A (he)
PE (1) PE20120863A1 (he)
PL (1) PL2475645T3 (he)
PT (1) PT2475645E (he)
RS (1) RS52987B (he)
RU (1) RU2541475C2 (he)
SG (1) SG179035A1 (he)
SI (1) SI2475645T1 (he)
TW (1) TWI412363B (he)
UA (1) UA107088C2 (he)
WO (1) WO2011029827A1 (he)
ZA (1) ZA201201599B (he)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012031817A1 (en) 2010-09-09 2012-03-15 F. Hoffmann-La Roche Ag Determination of abca1 protein levels in cells
US8410107B2 (en) 2010-10-15 2013-04-02 Hoffmann-La Roche Inc. N-pyridin-3-yl or N-pyrazin-2-yl carboxamides
US20120101282A1 (en) * 2010-10-22 2012-04-26 Pascal Dott Process for the preparation of nicotinamide derivatives
US8669254B2 (en) 2010-12-15 2014-03-11 Hoffman-La Roche Inc. Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents
WO2014180741A1 (en) * 2013-05-06 2014-11-13 F. Hoffmann-La Roche Ag Methods of identifying modulators of osbpl7 and the use of such modulators for treatment of diseases associated with osbpl7
US20200085810A1 (en) 2018-07-26 2020-03-19 Hoffmann-La Roche Inc. Compounds for use in treating kidney disorders
US11814354B2 (en) * 2021-09-08 2023-11-14 River 3 Renal Corp. Solid forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives
WO2006106054A1 (en) * 2005-04-06 2006-10-12 F. Hoffmann-La Roche Ag Pyridine-3-carboxamide derivatives as cb1 inverse agonists
BRPI0717845A2 (pt) 2006-10-04 2015-06-16 Hoffmann La Roche Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos

Also Published As

Publication number Publication date
EP2475645A1 (en) 2012-07-18
CL2012000611A1 (es) 2012-09-07
ZA201201599B (en) 2012-11-28
AU2010294277B2 (en) 2015-07-09
SG179035A1 (en) 2012-04-27
AR078352A1 (es) 2011-11-02
IL217920A0 (en) 2012-03-29
RU2541475C2 (ru) 2015-02-20
KR20120048040A (ko) 2012-05-14
IL217920A (he) 2015-11-30
SI2475645T1 (sl) 2013-10-30
CN102639506B (zh) 2014-09-03
AR114032A2 (es) 2020-07-15
CY1114377T1 (el) 2016-08-31
US8227491B2 (en) 2012-07-24
JP2013504534A (ja) 2013-02-07
TWI412363B (zh) 2013-10-21
AU2010294277A1 (en) 2012-02-09
IN2012DN00763A (he) 2015-06-26
UA107088C2 (xx) 2014-11-25
CA2771493A1 (en) 2011-03-17
JP5604520B2 (ja) 2014-10-08
KR101382871B1 (ko) 2014-04-08
TW201114427A (en) 2011-05-01
DK2475645T3 (da) 2013-07-22
BR112012005511A2 (pt) 2016-04-19
MA33563B1 (fr) 2012-09-01
RS52987B (en) 2014-02-28
WO2011029827A1 (en) 2011-03-17
ES2423821T3 (es) 2013-09-24
CO6491033A2 (es) 2012-07-31
BR112012005511B8 (pt) 2021-05-25
CN102639506A (zh) 2012-08-15
EP2475645B1 (en) 2013-07-03
MY161103A (en) 2017-04-14
ECSP12011723A (es) 2012-04-30
HRP20130869T1 (hr) 2013-10-25
US20110065759A1 (en) 2011-03-17
RU2012113924A (ru) 2013-10-20
PE20120863A1 (es) 2012-07-23
MX2012002254A (es) 2012-03-16
PT2475645E (pt) 2013-08-05
NZ597514A (en) 2013-10-25
CR20120089A (es) 2012-03-22
PL2475645T3 (pl) 2013-12-31
CA2771493C (en) 2017-08-29
BR112012005511B1 (pt) 2021-03-02

Similar Documents

Publication Publication Date Title
HK1172021A1 (en) 5-(3,4-dichloro-phenyl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro- ethoxy)-nicotinamide and salts thereof as hdl cholesterol raising agents hdl 5-(34--)-n-(2--)-6-(222-- )-
EP2360155A4 (en) 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
HK1135983A1 (en) Multi-substituted pyridyl sulfoximines and their use as insecticides
IL197577A0 (en) 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents
HK1183018A1 (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use 4-(4--2-)
IL204663A0 (en) Nicotinamide derivatives, preparastion thereof and therapeutic use thereof
EP1876178A4 (en) CYANOPYRIDINE DERIVATIVE AND THE USE THEREOF AS A MEDICAMENT
ZA200808191B (en) Pyridine and pyrimidine derivatives as MGLUR2 antagonists
IL217774A0 (en) Compositions for treating gaucher disease and uses thereof
IL220571A (he) תרכובות של 3–(3–פניל–אימידאזו[5,4–b]פירידיניל)–2–אמינופירידין המותמרות ותכשירים רוקחיים המכילים אותן
PT2493306E (pt) Composição herbicida sinergistica coontendo fluroxipir e cihalofop
HK1150555A1 (zh) 用於治療動脈硬化的 -嘧啶二元胺的應用
ZA200901132B (en) Human GLP-1 mimetibodies, compositions, methods and uses
RS52256B2 (sr) Terapeutske upotrebe jedinjenja sa kombinovanim sert, 5-ht3 i 5-ht1a aktivnostima
IL210937A (he) תרכובות חדשות של פניל–אמינו איזוניקוטינאמיד ושימוש בהן
HRP20171742T1 (hr) 2,4,6-trifluor-n-[6-(1-metilpiperidin-4-karbonil)piridin-2-il]benzamid, namijenjen liječenju migrene oralnom ili intravenskom primjenom
EP2276501A4 (en) METHODS AND COMPOSITIONS AGAINST GENETIC AND NETWORK DISEASES
IL197013A0 (en) Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
EP2497768A4 (en) NEW 2,4-PYRIMIDINE DERIVATIVES AND USES THEREOF
EP2190990A4 (en) PTHRP, its isoforms and antagonist for the diagnosis and treatment of diseases